A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: eminent (3), notable (38), well-known (4)

Communicating risk: words or numbers?

Description
Is it better to communicate risks to patients with words or statistics?
Url
/HealthProfessionals/Clinical-law-updates/Communicating-risk-words-or-numbers.aspx

Parental consent for their child's deprivation of liberty

Description
A court considers whether parents can consent to their child's deprivation of liberty.
Url
/HealthProfessionals/Clinical-law-updates/Parental-consent-for-their-childs-deprivation-of-liberty.aspx

Aspects of disclosure

Description
In a recent case, the Court of Appeal distinguished clearly the clinician's role in identifying the risks and complications inherent in
Url
/HealthProfessionals/Clinical-law-updates/Aspects-of-disclosure.aspx

Candid over complications

Description
Auto Generated Title When something has gone wrong during clinical management, it is now commonplace to expect that the patient or
Url
/HealthProfessionals/Clinical-law-updates/Candid-over-complications.aspx

Doctrine of double effect

Description
Auto Generated Title It is inevitable that we cause our patients harm during our attempts to deal with their disease or
Url
/HealthProfessionals/Clinical-law-updates/Doctrineofdoubleeffect.aspx

Two duties of candour

Description
In the summer of 2015, the views of the Department of Health (DH), the Nursing and Midwifery Council (NMC) and the
Url
/HealthProfessionals/Clinical-law-updates/Twodutiesofcandour.aspx

Acquiescence, not consent

Description
A court decides whether a Jehovah's Witness teenager should receive a blood transfusion when both he and his mother have refused
Url
/HealthProfessionals/Clinical-law-updates/Acquiescence-not-consent.aspx

Annual report 15-16

Description
University Hospital Southampton NHS Foundation Trust Annual report and accounts 2015/16 incorporating the quality account 20
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-15-16.pdf

Azacitidine5

Description
Chemotherapy Protocol Myelodysplastic Syndrome (MDS) Acute Myeloid Leukaemia (AML) Chronic Myelomonocytic Leukaemia (CMML) Azacitidine SC (5 days) This is an unlicensed s
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine5.pdf

Azacitidine5+2Ver1

Description
Chemotherapy Protocol Myelodysplastic Syndrome (MDS) Acute Myeloid Leukaemia (AML) Chronic Myelomonocytic Leukaemia (CMML) Azacitidine SC (5+2 days) This is not a license
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine5-2Ver1.pdf
11 to 20 of 35
Previous 1 2 3 4 Next